Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma: A Phase 2 Clinical Trial
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Camrelizumab (Primary) ; Temozolomide
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 25 Nov 2020 Status changed from not yet recruiting to recruiting.
- 14 Oct 2020 New trial record